Global Mercaptopurine Drugs Market Growth 2022-2028
- LP 4850269
- 71 Pages
- February 2022
- Pharmaceuticals
The United States Mercaptopurine Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Mercaptopurine Drugs market, reaching US$ million by the year 2028. As for the Europe Mercaptopurine Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Mercaptopurine Drugs players cover Nova Laboratories, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Mercaptopurine Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
20mg/ml
5mg/ml
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hosptial
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Nova Laboratories
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mercaptopurine Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Mercaptopurine Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Mercaptopurine Drugs by Country/Region, 2017, 2022 & 2028
2.2 Mercaptopurine Drugs Segment by Type
2.2.1 20mg/ml
2.2.2 5mg/ml
2.3 Mercaptopurine Drugs Sales by Type
2.3.1 Global Mercaptopurine Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Mercaptopurine Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Mercaptopurine Drugs Sale Price by Type (2017-2022)
2.4 Mercaptopurine Drugs Segment by Application
2.4.1 Hosptial
2.4.2 Pharmacy
2.5 Mercaptopurine Drugs Sales by Application
2.5.1 Global Mercaptopurine Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Mercaptopurine Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Mercaptopurine Drugs Sale Price by Application (2017-2022)
3 Global Mercaptopurine Drugs by Company
3.1 Global Mercaptopurine Drugs Breakdown Data by Company
3.1.1 Global Mercaptopurine Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Mercaptopurine Drugs Sales Market Share by Company (2020-2022)
3.2 Global Mercaptopurine Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Mercaptopurine Drugs Revenue by Company (2020-2022)
3.2.2 Global Mercaptopurine Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Mercaptopurine Drugs Sale Price by Company
3.4 Key Manufacturers Mercaptopurine Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mercaptopurine Drugs Product Location Distribution
3.4.2 Players Mercaptopurine Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Mercaptopurine Drugs by Geographic Region
4.1 World Historic Mercaptopurine Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Mercaptopurine Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Mercaptopurine Drugs Annual Revenue by Geographic Region
4.2 World Historic Mercaptopurine Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Mercaptopurine Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Mercaptopurine Drugs Annual Revenue by Country/Region
4.3 Americas Mercaptopurine Drugs Sales Growth
4.4 APAC Mercaptopurine Drugs Sales Growth
4.5 Europe Mercaptopurine Drugs Sales Growth
4.6 Middle East & Africa Mercaptopurine Drugs Sales Growth
5 Americas
5.1 Americas Mercaptopurine Drugs Sales by Country
5.1.1 Americas Mercaptopurine Drugs Sales by Country (2017-2022)
5.1.2 Americas Mercaptopurine Drugs Revenue by Country (2017-2022)
5.2 Americas Mercaptopurine Drugs Sales by Type
5.3 Americas Mercaptopurine Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mercaptopurine Drugs Sales by Region
6.1.1 APAC Mercaptopurine Drugs Sales by Region (2017-2022)
6.1.2 APAC Mercaptopurine Drugs Revenue by Region (2017-2022)
6.2 APAC Mercaptopurine Drugs Sales by Type
6.3 APAC Mercaptopurine Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Mercaptopurine Drugs by Country
7.1.1 Europe Mercaptopurine Drugs Sales by Country (2017-2022)
7.1.2 Europe Mercaptopurine Drugs Revenue by Country (2017-2022)
7.2 Europe Mercaptopurine Drugs Sales by Type
7.3 Europe Mercaptopurine Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mercaptopurine Drugs by Country
8.1.1 Middle East & Africa Mercaptopurine Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Mercaptopurine Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Mercaptopurine Drugs Sales by Type
8.3 Middle East & Africa Mercaptopurine Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mercaptopurine Drugs
10.3 Manufacturing Process Analysis of Mercaptopurine Drugs
10.4 Industry Chain Structure of Mercaptopurine Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mercaptopurine Drugs Distributors
11.3 Mercaptopurine Drugs Customer
12 World Forecast Review for Mercaptopurine Drugs by Geographic Region
12.1 Global Mercaptopurine Drugs Market Size Forecast by Region
12.1.1 Global Mercaptopurine Drugs Forecast by Region (2023-2028)
12.1.2 Global Mercaptopurine Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mercaptopurine Drugs Forecast by Type
12.7 Global Mercaptopurine Drugs Forecast by Application
13 Key Players Analysis
13.1 Nova Laboratories
13.1.1 Nova Laboratories Company Information
13.1.2 Nova Laboratories Mercaptopurine Drugs Product Offered
13.1.3 Nova Laboratories Mercaptopurine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Nova Laboratories Main Business Overview
13.1.5 Nova Laboratories Latest Developments
14 Research Findings and Conclusion
Table 1. Mercaptopurine Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Mercaptopurine Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 20mg/ml
Table 4. Major Players of 5mg/ml
Table 5. Global Mercaptopurine Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Mercaptopurine Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Mercaptopurine Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Mercaptopurine Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Mercaptopurine Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Mercaptopurine Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Mercaptopurine Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Mercaptopurine Drugs Revenue by Application (2017-2022)
Table 13. Global Mercaptopurine Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Mercaptopurine Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Mercaptopurine Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Mercaptopurine Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Mercaptopurine Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Mercaptopurine Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Mercaptopurine Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Mercaptopurine Drugs Producing Area Distribution and Sales Area
Table 21. Players Mercaptopurine Drugs Products Offered
Table 22. Mercaptopurine Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mercaptopurine Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Mercaptopurine Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Mercaptopurine Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Mercaptopurine Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Mercaptopurine Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Mercaptopurine Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Mercaptopurine Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Mercaptopurine Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Mercaptopurine Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Mercaptopurine Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Mercaptopurine Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Mercaptopurine Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Mercaptopurine Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Mercaptopurine Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Mercaptopurine Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Mercaptopurine Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Mercaptopurine Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Mercaptopurine Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Mercaptopurine Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Mercaptopurine Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Mercaptopurine Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Mercaptopurine Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Mercaptopurine Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Mercaptopurine Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Mercaptopurine Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Mercaptopurine Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Mercaptopurine Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Mercaptopurine Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Mercaptopurine Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Mercaptopurine Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Mercaptopurine Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Mercaptopurine Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Mercaptopurine Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Mercaptopurine Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Mercaptopurine Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Mercaptopurine Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Mercaptopurine Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Mercaptopurine Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Mercaptopurine Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Mercaptopurine Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Mercaptopurine Drugs
Table 66. Key Market Challenges & Risks of Mercaptopurine Drugs
Table 67. Key Industry Trends of Mercaptopurine Drugs
Table 68. Mercaptopurine Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Mercaptopurine Drugs Distributors List
Table 71. Mercaptopurine Drugs Customer List
Table 72. Global Mercaptopurine Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Mercaptopurine Drugs Sales Market Forecast by Region
Table 74. Global Mercaptopurine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Mercaptopurine Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Mercaptopurine Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Mercaptopurine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Mercaptopurine Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Mercaptopurine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Mercaptopurine Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Mercaptopurine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Mercaptopurine Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Mercaptopurine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Mercaptopurine Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Mercaptopurine Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Mercaptopurine Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Mercaptopurine Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Mercaptopurine Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Mercaptopurine Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Mercaptopurine Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Mercaptopurine Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Nova Laboratories Basic Information, Mercaptopurine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Nova Laboratories Mercaptopurine Drugs Product Offered
Table 94. Nova Laboratories Mercaptopurine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Nova Laboratories Main Business
Table 96. Nova Laboratories Latest Developments
List of Figures
Figure 1. Picture of Mercaptopurine Drugs
Figure 2. Mercaptopurine Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mercaptopurine Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Mercaptopurine Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Mercaptopurine Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 20mg/ml
Figure 10. Product Picture of 5mg/ml
Figure 11. Global Mercaptopurine Drugs Sales Market Share by Type in 2021
Figure 12. Global Mercaptopurine Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Mercaptopurine Drugs Consumed in Hosptial
Figure 14. Global Mercaptopurine Drugs Market: Hosptial (2017-2022) & (K Units)
Figure 15. Mercaptopurine Drugs Consumed in Pharmacy
Figure 16. Global Mercaptopurine Drugs Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Global Mercaptopurine Drugs Sales Market Share by Application (2017-2022)
Figure 18. Global Mercaptopurine Drugs Revenue Market Share by Application in 2021
Figure 19. Mercaptopurine Drugs Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Mercaptopurine Drugs Revenue Market Share by Company in 2021
Figure 21. Global Mercaptopurine Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Mercaptopurine Drugs Revenue Market Share by Geographic Region in 2021
Figure 23. Global Mercaptopurine Drugs Sales Market Share by Region (2017-2022)
Figure 24. Global Mercaptopurine Drugs Revenue Market Share by Country/Region in 2021
Figure 25. Americas Mercaptopurine Drugs Sales 2017-2022 (K Units)
Figure 26. Americas Mercaptopurine Drugs Revenue 2017-2022 ($ Millions)
Figure 27. APAC Mercaptopurine Drugs Sales 2017-2022 (K Units)
Figure 28. APAC Mercaptopurine Drugs Revenue 2017-2022 ($ Millions)
Figure 29. Europe Mercaptopurine Drugs Sales 2017-2022 (K Units)
Figure 30. Europe Mercaptopurine Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Mercaptopurine Drugs Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Mercaptopurine Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Americas Mercaptopurine Drugs Sales Market Share by Country in 2021
Figure 34. Americas Mercaptopurine Drugs Revenue Market Share by Country in 2021
Figure 35. United States Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Mercaptopurine Drugs Sales Market Share by Region in 2021
Figure 40. APAC Mercaptopurine Drugs Revenue Market Share by Regions in 2021
Figure 41. China Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Mercaptopurine Drugs Sales Market Share by Country in 2021
Figure 48. Europe Mercaptopurine Drugs Revenue Market Share by Country in 2021
Figure 49. Germany Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Mercaptopurine Drugs Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Mercaptopurine Drugs Revenue Market Share by Country in 2021
Figure 56. Egypt Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Mercaptopurine Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Mercaptopurine Drugs in 2021
Figure 62. Manufacturing Process Analysis of Mercaptopurine Drugs
Figure 63. Industry Chain Structure of Mercaptopurine Drugs
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
